WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 564

Legislative bill overview

HB 564 would require health benefit plans in Texas to cover evidence-based treatments for autism spectrum disorder (ASD). The bill mandates coverage of behavioral health treatments, which typically include applied behavior analysis (ABA) and related therapeutic interventions for individuals diagnosed with ASD.

Why is this important

Autism spectrum disorder affects approximately 1 in 36 children in the U.S., and evidence-based behavioral interventions can significantly improve outcomes. Many families face substantial out-of-pocket costs for ASD treatment, which can exceed $60,000 annually, making insurance coverage a critical access issue for middle and lower-income families.

Potential points of contention

  • Insurance cost implications: Mandated coverage requirements increase premiums for all plan members, raising questions about cost-benefit tradeoffs and who bears the financial burden
  • Definition of "evidence-based": Disagreement exists over which treatments qualify as evidence-based; some insurers may dispute coverage of certain therapies, and the bill's specificity on this matters significantly
  • Age and duration limits: Questions remain about coverage duration (through age 18? adulthood?) and intensity requirements, which affect both accessibility and costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.